Artículos por temáticas

The Mitochondrial Foundations of Parkinson's Disease: Therapeutic Implications

Soman SK, Woodruff MRJ, Dagda RK.

Aging Dis. 2025 Jun 18. doi: 10.14336/AD.2025.0440. Online ahead of print.

Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -Current status of the Kyoto Trial and future perspectives

Takahashi R, Nakanishi E, Yamakado H, Sawamoto N, Takahashi J.

Parkinsonism Relat Disord. 2025 Jun;135:107833. doi: 10.1016/j.parkreldis.2025.107833. Epub 2025 Apr 19.

Impact of Parkinson's disease diagnosis validity on the association with cancer: A systematic review and meta-analysis

Mehdiyeva A, Kaasinen V, Heervä E, Sipilä JOT.

Parkinsonism Relat Disord. 2025 Jun;135:107846. doi: 10.1016/j.parkreldis.2025.107846. Epub 2025 Apr 22.

Clinical and Functional Connectivity Markers in Prediction of Hallucinations in Parkinson's Disease

Li G, Jiang M, Chen X, Hu P, Liu J, Wang K.

CNS Neurosci Ther. 2025 Jun;31(6):e70432. doi: 10.1111/cns.70432.

Alpha-synuclein pathology and Parkinson's disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches

Abraham JN, Rawat D, Srikanth P, Sunny LP, Abraham NM.

Mamm Genome. 2025 Jun;36(2):444-464. doi: 10.1007/s00335-025-10128-w. Epub 2025 Apr 28.

Molecular mechanisms of neuroprotective effect of rutin

Chunmei Z, Shuai W.

Front Pharmacol. 2025 Jun 3;16:1599167. doi: 10.3389/fphar.2025.1599167. eCollection 2025.

The critical role of GLP-1 signaling pathways in the pathology of Parkinson's disease and diabetes

Chen J, Dong X, Lin Y, Lv C.

Pathol Res Pract. 2025 Jun;270:155985. doi: 10.1016/j.prp.2025.155985. Epub 2025 Apr 22.

Dancing towards speech improvement: Repurposing dance for motor speech deficits in neurodegenerative diseases

Theofanopoulou C.

J Alzheimers Dis. 2025 Jun;105(4):1085-1096. doi: 10.1177/13872877241313304. Epub 2025 Jan 27.

Neuroadaptation in neurodegenerative diseases: compensatory mechanisms and therapeutic approaches

Kopalli SR, Behl T, Baldaniya L, Ballal S, Joshi KK, Arya R, Chaturvedi B, Chauhan AS, Verma R, Patel M, Jain SK, Wal A, Gulati M, Koppula S.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Jun 20;139:111375. doi: 10.1016/j.pnpbp.2025.111375. Epub 2025 Apr 23.

Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates

Guo X, Xiang J, Ye K, Zhang Z.

Cells. 2025 Jun 16;14(12):907. doi: 10.3390/cells14120907.

Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseases

Ramos-Vicente D, Monterosso P, de Fàbregues O, Roch G, Vila M, Bové J.

Front Immunol. 2025 May 29;16:1599303. doi: 10.3389/fimmu.2025.1599303. eCollection 2025.

[Drug-induced Parkinsonism as Viewed from Neurologist]

Tomiyama M.

Brain Nerve. 2025 Jun;77(6):715-719. doi: 10.11477/mf.188160960770060715.

NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy

Svenningsson P, Odin P, Bergquist F, Wirdefeldt K, Nyholm D, Andréasson M, Markaki I, Johansson AC, Jergil M, Jankosky C, Varney MA, Herbrecht F, Johnson SA, Newman-Tancredi A.

Mov Disord. 2025 Jun;40(6):1134-1142. doi: 10.1002/mds.30175. Epub 2025 Mar 17.

The Role of Inflammation in Neurodegenerative Diseases: Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis

Fołta J, Rzepka Z, Wrześniok D.

Int J Mol Sci. 2025 May 28;26(11):5177. doi: 10.3390/ijms26115177.

Catecholamine Dysregulation in Former American Football Players: Findings From the DIAGNOSE CTE Research Project

van Amerongen S, Peskind ER, Tripodis Y, Adler CH, Balcer LJ, Bernick C, Alosco ML, Katz D, Banks SJ, Barr WB, Cantu RC, Dodick DW, Geda YE, Mez J, Wethe JV, Weller JL, Daneshvar DH, Palmisano J, Fagl

Neurology. 2025 May 27;104(10):e213584. doi: 10.1212/WNL.0000000000213584. Epub 2025 Apr 21.